Share on LinkedInShare on LinkedIn

ARTICLE · 09 JULY 2024

Canada's PMPRB Guidelines: Many A Winding Turn

Torys
Torys
Contributor
Torys

Torys

Torys LLP is an international business law firm that works with clients who expect the best advice...

View firm profile
Explore more from Torys

As the Hollies' song indicates, "[t]he road is long, with many a winding turn"1. This is an apt phrase vis-à-vis Canada's Patented Medicine Prices Review Board (PMPRB) guidelines.

CanadaIntellectual Property

As the Hollies' song indicates, "[t]he road is long, with many a winding turn"1. This is an apt phrase vis-à-vis Canada's Patented Medicine Prices Review Board (PMPRB) guidelines.

On June 26, 2024, the PMPRB published a consultation document called Shaping the Future: A Discussion Guide for PMPRB Phase 2 Consultations on New Guidelines (the Discussion Guide). Feedback on the topics addressed in the Discussion Guide will be used by the PMPRB to develop non-binding guidelines (Guidelines) that will operationalize the requirements of the Patented Medicines Regulations (PMR). The new Guidelines are intended to give effect to amendments to the PMR, reflect judicial decisions and increase efficiency. Notably, the PMR now includes a basket of 11 countries (the PMPRB11)2, whose list prices are used as comparators to determine whether the price of a patented medicine in Canada is excessive.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from